
MIG Fonds 18 is a closed-end German venture capital vehicle investing in early and growth-stage European tech firms across biotech, digital health, robotics, and other future-facing sectors. The fund is structured as a German KG with six equal capital calls and a term to 2037. It emphasizes ecological and social impact through ESG-aligned criteria and excludes certain controversial industries. There is no liquidity, no leverage, and no redemption prior to maturity. Open until 31 December 2026.
Fund Size
€100M
Target Return
10.4%
Realized annualized return since inception
N/A
Launch Year
2024
Min. Investment
€6,000
Liquidity Level
Low (5+ years)
Liquidity Options
No redemptions, 2037 maturity
Structure
Investment-KG
Product Category
Closed-end
Domicile
Germany
GP Type
Single
Management Fee
13.33%
Carry
None%
High Water Mark
No
Availability
Open for public
Currencies
EUR
ISIN
Not disclosed
KID Risk Indicator
6 out of 7
Annual returns (KID)
Stressed
-4.6%
Moderate
3%
Favorable
10.4%
Average total cost level (KID)
5.14%
MIG Fonds 18 is a direct venture capital fund, not a fund-of-funds. It invests directly in startups, primarily in high-tech sectors like biotech, medtech, and digital health. There's no intermediary layer of private equity funds underneath.
At the same time, it is marketed to retail investors. That’s unusual for VC, which is typically institutional territory. MIG has structured this as a German closed-end retail vehicle with features like capital calls, lock-up until 2037, and relatively low minimum investment thresholds (starting at €5,000 or €3,000 per capital call tranche). Of course, this comes with a different cost structure compared to traditional VC funds, which are primarily marketed to institutional investors (often with €1m minimum tickets or higher).
These details were written by FundScouter, and may have mistakes.
If you are affiliated with this fund and want to request an update, send an email to: report@fundscouter.com